AMH
8
1
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Effect of Antimullerian Hormone Levels on the Inflammatory Index, Phytochemical Index and NRF Nutrient Density
In Vitro Maturation of Human Eggs
Hormones in Hypogonadotropic Hypogonadism
AMHR2 Polymorphism in Blood and Granulosa Cells in Unexplained Infertility
Predictive Value of New AMH Test Method for Ovarian Response
AMH and Pregnancy Outcome in IVF
Serum AMH Levels in Patients Who Underwent Hypogastric Artery Ligation
Ovarian Function and Reserve Parameters After Discontinuation of Long-term Use of Oral Contraception